Yesterday, May 25, 2016, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $88.32 to $137,937,966.40.

Highlighted Stocks Traded by Insiders:

Rudolph Technologies (RTEC) - FREE Research Report

Berry Daniel H, who is Director at Rudolph Technologies, sold 5,000 shares at $14.35 on May 25, 2016. Following this transaction, the Director owned 16,500 shares meaning that the stake was reduced by 23.26% with the 5,000-share transaction.

Roy Rajiv, who is Shareholder at Rudolph Technologies, sold 4,063 shares at $14.39 on May 25, 2016. Following this transaction, the Shareholder owned 26,740 shares meaning that the stake was reduced by 13.19% with the 4,063-share transaction.

The shares most recently traded at $14.40, up $0.01, or 0.07% since the insider transaction. Historical insider transactions for Rudolph Technologies go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 10,697
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 10,697
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 10,697

The average volume for Rudolph Technologies has been 247,600 shares per day over the past 30 days. Rudolph Technologies has a market cap of $443.5 million and is part of the technology sector and electronics industry. Shares are up 0.77% year-to-date as of the close of trading on Wednesday.

Rudolph Technologies, Inc. designs, develops, manufactures, and supports process control defect inspection and metrology, advanced packaging lithography, and data analysis systems and software used in microelectronic device manufacturing. The company has a P/E ratio of 15.3. Currently, there are 4 analysts who rate Rudolph Technologies a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RTEC - FREE

TheStreet Quant Ratings

rates Rudolph Technologies as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Rudolph Technologies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

US Physical Therapy (USPH) - FREE Research Report

Harris Bernard A Jr, who is Director at US Physical Therapy, sold 2,912 shares at $19.75 on May 25, 2016. Following this transaction, the Director owned 2,138 shares meaning that the stake was reduced by 57.66% with the 2,912-share transaction.

The shares most recently traded at $57.01, up $37.26, or 65.36% since the insider transaction. Historical insider transactions for US Physical Therapy go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 30,354
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 40,354
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 48,854

The average volume for US Physical Therapy has been 93,800 shares per day over the past 30 days. US Physical Therapy has a market cap of $722.7 million and is part of the health care sector and health services industry. Shares are up 7.06% year-to-date as of the close of trading on Wednesday.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The stock currently has a dividend yield of 1.18%. The company has a P/E ratio of 30.6. Currently, there is 1 analyst who rates US Physical Therapy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USPH - FREE

TheStreet Quant Ratings

rates US Physical Therapy as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

US Physical Therapy Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Turtle Beach (HEAR) - FREE Research Report

Bonanno Carmine J, who is 10% Owner at Turtle Beach, sold 132,145 shares at $1.02 on May 25, 2016. Following this transaction, the 10% Owner owned 4.8 million shares meaning that the stake was reduced by 2.69% with the 132,145-share transaction.

The shares most recently traded at $0.99, down $0.03, or 2.78% since the insider transaction. Historical insider transactions for Turtle Beach go as follows:

  • 4-Week # shares bought: 3.2 million
  • 4-Week # shares sold: 492,295
  • 12-Week # shares bought: 3.2 million
  • 12-Week # shares sold: 492,295
  • 24-Week # shares bought: 3.2 million
  • 24-Week # shares sold: 492,995

The average volume for Turtle Beach has been 224,500 shares per day over the past 30 days. Turtle Beach has a market cap of $51.7 million and is part of the technology sector and telecommunications industry. Shares are down 50.75% year-to-date as of the close of trading on Wednesday.

Turtle Beach Corporation, an audio technology company, develops, commercializes, and markets audio technologies under the Turtle Beach and HyperSound brands in the United States, the United Kingdom, Europe, and internationally. Currently, there are 4 analysts who rate Turtle Beach a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HEAR - FREE

TheStreet Quant Ratings

rates Turtle Beach as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Turtle Beach Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.